IRCT20191213045719N1
Recruiting
Phase 3
Comparison of the Effectiveness of intradermal injected tranexamic acid50mg/ml plus ascorbic acid50mg/ml VS tranexamic acid50mg/ml in the treatment of melasma:A split face comparative trial
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ahvaz University of Medical Sciences
- Enrollment
- 24
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women at the range of 18 to 50 years old
- •patients with symmetrical bilateral melasma
Exclusion Criteria
- •Patient who is pregnant or in lactation period
- •Patient who had taken oral contraceptive pill in 12 months ago
- •Patient who has history of coagulopathy and thrombotic disorder
- •Patient who ia taking anticoagulant and antiepileptic drug
- •Patient who has sensitivity to tranexamic acid
- •Patient who has history of treatment for melasma during 1 month ago
- •Patient who has active facial herpes simplex virus infection
- •Patient who has facial wart
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Comparison of the Efficacy of Intradermal injected Tranexamic Acid vs Hydroquinone cream in the Treatment of MelasmaIRCT20180203038599N1Ahvaz University of Medical Sciences40
Recruiting
Phase 3
The effect of tranexamic acid and hydroquinone in melasmaIRCT20180909040979N5Ahvaz University of Medical Sciences48
Recruiting
Phase 3
Comparison of the effect of Botox injection in reducing the size of facial poresarge pores of facial skin.IRCT20210321050754N1Ahvaz University of Medical Sciences33
Recruiting
Not Applicable
A study to compare efficacy of intradermal Tranexamic acid injections versus topical Tranexamic acid gel versus topical triple combination (Hydroquinone 2 %, Tretinion 0.025%, Flucinolone acetonide 0.01%) cream in patients suffering from melasmaCTRI/2017/07/009158MGM Medical COllege and Hospital180
Not yet recruiting
Not Applicable
Comparative study of Intradermal versus Intralesional Purified Protein Derivative (PPD) for treatment of common warts in childreHealth Condition 1: L088- Other specified local infections of the skin and subcutaneous tissueCTRI/2019/07/020070Himachal Pradesh University